# A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture

> **NCT00528931** · PHASE1 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 16 (actual)

## Conditions studied

- Dupuytren's Contracture

## Interventions

- **BIOLOGICAL:** collagenase clostridium histolyticum

## Key facts

- **NCT ID:** NCT00528931
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2007-12
- **Final completion:** 2008-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528931, "A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00528931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*